# Ambrosia Biosciences funding rounds and investors

As of 14 Oct 2026, Ambrosia Biosciences has raised $100M across 1 verified round on record; latest: $100 million Series B led by Blue Owl Healthcare Opportunities, Deep Track Capital and 1 other, announced 31 Mar 2026.

Small molecule-based therapies for obesity and metabolic disorders, aimed at healthcare providers and patients.

Website: https://ambrosiabiosciences.com  
Page: https://fireround.dev/companies/ambrosiabiosciences.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-03-31 | Series B | $100 million | Blue Owl Healthcare Opportunities, Deep Track Capital, Redmile Group | Boulder Ventures, BVF Partners, Janus Henderson Investors, Samsara BioCapital | [prnewswire.com](https://www.prnewswire.com/news-releases/ambrosia-biosciences-announces-100-million-oversubscribed-series-b-financing-to-advance-novel-small-molecule-cardiometabolic-pipeline-302729104.html) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.